Among them, 6 patients had TP53 variants, and their TP53 variants co-existed in the ctDNA and DNA from tumor biopsies (Supplementary Table S1 and Supplementary Figure S2), suggesting the TP53 variants origin from breast cancer, not CHIP mutations. This evidence concerns the gene TP53 and neoplasm.